Category
page 12006 in London
poisoning of Alexander Litvinenko
2006 fatal poisoning of a former FSB and KGB officer
59th British Academy Film Awards
2006 edition of the BAFTAs
theralizumab
Theralizumab (also known as TGN1412, CD28-SuperMAB, and TAB08) is an immunomodulatory drug developed by immunologist of the University of Würzburg. It was withdrawn from development after inducing severe inflammatory reactions as well as chronic organ failure in the first-in-human study by Parexel in London in March 2006. The developing company, TeGenero Immuno Therapeutics (), a spin-off of the University of Würzburg around immunologist Thomas Hünig, co-founder and chief scientific officer (CSO) Thomas Hanke and chief executive officer (CEO) Benedikte Hatz went bankrupt later that year. The c
Guy Goma
Congolese student
Brit Awards 2006
2006 edition of annual pop music awards ceremony
Shoreditch
former London Underground station
11th Empire Awards
2006 British film awards ceremony
British Independent Film Awards 2006
9th British Independent Film Awards